BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
01.08.23
/
50%
€79.72
Target price
01.08.24
€113.91
Performance (%)
-3.59%
End price
02.08.24
€76.86
Summary
This prediction ended on 02.08.24 with a price of €76.86. With a performance of -3.59%, the BUY prediction for BioMarin Pharmaceutical Inc. by Morgan_Stanley closed slightly in the red. Morgan_Stanley has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.138% | 5.138% | -19.321% |
| iShares Core DAX® | 0,02 % | 0,58 % | 11,67 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % | 4,18 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % | 29,99 % |
| iShares S&P 500 | 1,33 % | 0,14 % | 3,33 % |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $129.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€48.80
03.07.25
03.07.25
€82.17
03.07.26
03.07.26
9.96%
14:59
14:59
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€84.06
28.10.26
28.10.26
14.41%
14:59
14:59
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.36
22.07.25
22.07.25
€82.12
22.07.26
22.07.26
6.55%
14:59
14:59
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
-26.63%
27.04.25
27.04.25